[

virus drug

]
A lab technician visually inspects a filled vial of investigational coronavirus disease (COVID-19) treatment drug remdesivir at a Gilead Sciences facility in La Verne, California(via REUTERS)

Gilead stuck amid profit and virus drug

Minneapolis | By Bloomberg
PUBLISHED ON MAY 02, 2020 03:24 AM IST
Details from a US government study and a separate trial conducted by the company itself suggest remdesivir may become the first medication approved to treat the novel coronavirus, which has sickened 3.2 million people worldwide and killed 233,000.
SHARE
Story Saved